PSEC Insiders Buy as Borrow Costs Ease Into Earnings
Prospect Capital Corporation reports fiscal Q3 results today with the borrow market considerably looser than it was six weeks ago — a notable shift for a stock that remains one of the more heavily shorted names in the BDC space.
Short interest has retreated meaningfully since early April, falling from roughly 38 million shares to around 34 million. That puts SI % of free float at 7%, down nearly 9% on a month-over-month basis. Cost to borrow has followed suit: it fell sharply over the past week to 3.84% after briefly spiking above 19% in late March. Availability is running at 165% of short interest — ample room in the lending pool relative to positions already outstanding. The lending market has loosened considerably since the brief squeeze conditions of late March.
Options positioning tells a similar, relaxed story. The put/call ratio is close to flat on its 20-day average at 0.33, just one standard deviation above the mean — there is no concentrated demand for downside protection heading into the print. The stock itself has recovered modestly, up 4.2% over the past month to $2.75, though it slipped 1.1% on Thursday ahead of the release.
The insider angle is harder to ignore. CEO John Barry and President Michael Eliasek have been persistent buyers. Barry made cluster purchases across September 2025 totalling more than $6.5 million across four trading days. Eliasek followed in February 2026 with a $2.75 million purchase at $2.92 — the most recent trade on record. That sustained, high-value buying from the top of the house is a clear signal of management conviction at these price levels.
Analyst coverage has been sparse and consistently bearish. Wells Fargo has maintained an Underweight rating and has lowered its price target in step with every earnings cycle — from $6.50 in early 2023 down to $2.50 by August 2025. The current stock price of $2.75 already sits above that target, creating a notable gap between the only visible analyst view and where the market has the stock trading. That divergence — insiders buying aggressively while the one covering analyst lowers the bar every quarter — frames the core debate heading into today's release.
The earnings print already arrived after Wednesday's close: Q3 EPS of $0.16 beat the $0.11 estimate, but revenue of $150.1 million missed the $163.2 million consensus. Today's conference call will test whether the earnings beat and insider conviction are enough to offset the revenue shortfall in a market still asking questions about PSEC's net asset value trajectory.
See the live data behind this article on ORTEX.
Open PSEC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
